Undenatured type II collagen and its role in improving osteoarthritis

Area of Science:

• Biochemistry and Molecular Biology
• Rheumatology
• Nutritional Science

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease with no cure, impacting millions globally.
• Articular cartilage, crucial for joint function, is primarily composed of Type II collagen.
• Current treatments for OA focus on symptom management and disease modification.

Purpose of the Study:

• To review the research progress on undenatured type II collagen (UC-II) for osteoarthritis.
• To explore UC-II's extraction, preparation, characterization, and stability.
• To elucidate the mechanism of action and therapeutic potential of UC-II in OA.

Main Methods:

• Literature review of studies on undenatured type II collagen.
• Analysis of extraction and preparation methods, including limited enzymatic hydrolysis for soluble collagen (SC II).
• Evaluation of factors affecting SC II stability (source, pH, ions, temperature) and UC-II activity (source, denaturation, dose).

Main Results:

• Oral administration of UC-II demonstrates significant potential in reducing OA incidence and alleviating symptoms.
• Soluble undenatured type II collagen (SC II) preparation involves limited enzymatic hydrolysis, with stability influenced by various factors.
• While UC-II's efficacy is supported, the precise influence of its structure on activity and the detailed mechanism remain areas for further investigation.

Conclusions:

• Undenatured type II collagen holds significant therapeutic potential as an intervention or auxiliary treatment for osteoarthritis.
• Further research is needed to clarify the structure-activity relationship and the exact mechanism of action of UC-II.
• Optimizing extraction, preparation, and administration of UC-II could enhance its clinical application in managing OA.